PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer.
Julia E DouglasSuyu LiuJunsheng MaRobert A WolffShubham PantAnirban MaitraEric P TammPriya BhosaleMatthew H G KatzGauri R VaradhacharyEugene Jon KoayPublished in: BMC cancer (2022)
This study is approved by the Institutional Review Board (IRB) of MD Anderson Cancer Center, IRB-approved protocol 2020-0075. The PIONEER trial is registered at the US National Institutes of Health (ClinicalTrials.gov) NCT04481204 .
Keyphrases
- phase ii
- open label
- clinical trial
- phase iii
- placebo controlled
- double blind
- healthcare
- public health
- papillary thyroid
- drug administration
- mental health
- study protocol
- randomized controlled trial
- high throughput
- molecular dynamics
- risk assessment
- health information
- human health
- young adults
- climate change
- single cell
- lymph node metastasis